NewsSource: EClinCloud

Conference Preview | EClinCloud Invited to the 7th CMAC Annual Conference 2022 to Discuss Scientific DtP Drug Distribution

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration
Article illustration

Speaker: Dr. Qin Long

CEO, EClinCloud

Presentation Topic:

Supply Chain Management in DCT Clinical Studies - Direct-to-Patient Drug Distribution


Time of Presentation:

July 10

10:15-10:30




DtP Is an Important Approach for Supporting DCT Studies

Since the outbreak of the pandemic in 2020, industry demand for Decentralized Clinical Trials (DCT) has grown steadily, and the Direct-to-Patient (DtP) drug distribution model is an important means of supporting DCT studies. DtP refers to a distribution model in which investigational drugs are shipped from a drug depot or study site to a participant's home1. In currently conducted clinical studies, the primary way for participants to obtain study medication is by traveling to the study site in person to collect it. This method places a substantial burden on participants who require long-term visits or live in remote areas, which can easily lead to recruitment difficulties or patient dropout.





Potential Risks of DtP

China is still at an exploratory stage regarding how to conduct DtP drug distribution scientifically and effectively in drug clinical trials. Two potential risks in DtP urgently need to be addressed. First, how can shipping and logistics be coordinated? Second, can the investigator accurately trace the investigational drug throughout the entire study?





How Can Risks Be Reduced?

To address these issues, the Randomization and Trial Supply Management (RTSM) system plays a key role. An RTSM system can help investigators carry out multiple key trial steps, such as participant randomization, drug blinding, drug shipment and distribution, and participant dispensing records. Its robust capabilities for drug shipment data tracking, transit monitoring, and shipping event management provide complete drug traceability, ensure the integrity of DtP trials, and greatly reduce shipment coordination risks. What specific data does it track, and how are shipping events managed scientifically? Follow the 2022 CMAC Annual Conference, where Dr. Qin Long will address each of these questions.


References

1. Hu Min, Zuo Zejin. Discussion on Direct-to-Patient (DTP) Drug Transportation Models in Drug Clinical Trials. China Food and Drug Supervision, 2020(11):8.



Article illustration
Article illustration

Where Is the Conference Venue?

Hangzhou International Expo Center (353 Benjing Avenue)

Article illustration

How Can I Watch the Livestream If I Cannot Attend in Person?

Please follow the CMAC official WeChat account to watch the livestream.



About EClinCloud


EClinCloud provides an integrated, all-in-one cloud platform (including solutions such as CTMS, eTMF, EDC, RTSM, eCOA, and eConsent, as well as consulting services including scale management, linguistic validation, rater training, study build and configuration, and data quality analysis) along with clinical trial endpoint assessment technologies across therapeutic areas (including oncology, neurology, cardiology, pulmonology, and dermatology, among others). By combining cutting-edge technology with life data, EClinCloud is building a globally leading, patient-centric SaaS cloud platform for clinical evidence support, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.





Article illustration

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.